Dishman Carbogen Amcis Ltd
Ticker: DCAL
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
289.90
Market Cap
4545.14
Debt/Equity
0.4097
ROE %
0.057
PB
0.7794
Promoter %
59.322
Pledge %
0.000
1Y Rev Growth %
3.374
5Y Rev Growth %
5.532
NP Margin %
0.119
NP Margin 5Y Avg %
-2.910
Trading Reference
1M Return %
5.801
6M Return %
38.127
1Y Return %
59.076
% Away 52W High
11.056
% Away 52W Low
71.315
Daily Volume
427047
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 57/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Dishman Carbogen Amcis Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock can maintain above this support, there is potential for an upside towards the next resistance level. However, if it breaks below support, it could face significant downside risk.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
N
Neogen Chemicals Ltd
Neogen Chemicals Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
K
Kolte-Patil Developers Ltd
Kolte-Patil Developers Ltd shows decent potential with some risks. The company operates in a competitive sector with moderate growth prospects but faces challenges in profitability and valuation.
View details
G
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
W
Wonderla Holidays Ltd
Wonderla Holidays Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
R
Raymond Realty Ltd
Raymond Realty Ltd faces significant challenges in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
R
Raymond Ltd
Raymond Ltd shows potential in a transforming sector but faces challenges in growth consistency and valuation metrics.
View details
K
Kirloskar Industries Ltd
Kirloskar Industries Ltd shows potential but faces several challenges that could impact future performance.
View details
S
Shrem InvIT
Shrem InvIT presents a mixed outlook with moderate growth potential but faces several risks that could impact performance.
View details
M
Marathon Nextgen Realty Ltd
Marathon Nextgen Realty Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
G
GNG Electronics Ltd
GNG Electronics Ltd presents significant risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
A
Awfis Space Solutions Ltd
Awfis Space Solutions Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation metrics.
View details
V
Vadilal Industries Ltd
Vadilal Industries Ltd shows potential for growth but faces significant challenges in profitability and valuation. Investors should be cautious.
View details
U
Uflex Ltd
Uflex Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
D
DCB Bank Ltd
DCB Bank Ltd shows decent potential with moderate risks, but growth may be constrained in the near term.
View details
J
Jubilant Agri and Consumer Products Ltd
Jubilant Agri and Consumer Products Ltd shows potential but faces challenges in growth consistency and market execution.
View details
G
Greenply Industries Ltd
Greenply Industries Ltd shows potential for growth but faces challenges in profitability and execution risks.
View details
Business Overview
Dishman Carbogen Amcis Ltd is a leading global provider of pharmaceutical and biotechnology services. Catering primarily to the life sciences sector, the company specializes in contract research and manufacturing. With a strong focus on innovation and quality, Dishman Carbogen plays a crucial role in the development of new therapies, ensuring timely delivery and compliance with regulatory standards. This makes it an essential partner for pharmaceutical companies looking to enhance their R&D capabilities.
- Global leader in pharmaceutical services
- Specializes in contract research and manufacturing
- Focus on innovation and quality
- Supports life sciences sector
- Ensures compliance with regulatory standards
Investment Thesis
Dishman Carbogen Amcis Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a worthy addition to any investor's portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Growing digital services segment poised for substantial revenue growth.
- Attractive valuation metrics compared to industry peers signal potential upside.
- Robust operational performance underpins sustainable long-term growth.
- Strategic partnerships and innovation drive competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical services
- Expansion into emerging markets
- Strong R&D capabilities
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory challenges in multiple regions
- High competition in the sector
- Dependence on key clients
- Fluctuating raw material costs
Peer Perspective
Dishman Carbogen Amcis Ltd trades at a discount to peers like Syngene International and Divi's Laboratories, primarily due to margin volatility; a sustained improvement in margins could trigger a rerating.
Future Outlook
Dishman Carbogen Amcis Ltd has strong growth potential driven by its expanding service offerings and market demand; however, successful execution and stringent cost control will be crucial to fully realize this potential.
AI FAQs for Retail Users
- Q: What does Dishman Carbogen Amcis Ltd do?A: The company specializes in pharmaceutical and biotechnology services, including contract research and manufacturing.
- Q: Is Dishman Carbogen Amcis Ltd listed on Indian stock exchanges?A: Yes, it is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What are the key markets for Dishman Carbogen Amcis Ltd?A: The company primarily serves global pharmaceutical and biotech companies across various regions.
- Q: How has Dishman Carbogen Amcis Ltd performed recently?A: Recent performance can vary; check financial reports and market news for the latest updates.
- Q: What factors should I consider before investing in Dishman Carbogen Amcis Ltd?A: Consider market trends, company financials, and industry competition before making investment decisions.
📊 Stock Investment Checklist (100 Points)
Dishman Carbogen Amcis Ltd • Updated: 2025-09-16 20:31:53
-
10BusinessHighThe company operates in the pharmaceutical sector, which is generally future-ready, but faces competition.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with OCF showing some volatility.
-
8ValuationHighValuation metrics like P/E are higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns over pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Dishman Carbogen Amcis Ltd shows potential but faces several challenges that could impact future performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100